Oryzon Genomics SA (ORYZF)
3.25
-0.35
(-9.72%)
USD |
OTCM |
Mar 05, 16:00
Oryzon Genomics EPS Diluted (Quarterly) : -0.0202 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Grifols SA | 0.168 |
| Pharma Mar SA | 3.978 |
| Laboratorios Farmaceúticos Rovi SA | 0.9711 |
| Almirall SA | -- |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.568M |
| Total Expenses (Quarterly) | 1.568M |
| Enterprise Value | 236.98M |
| Earnings Yield | -1.26% |
| Normalized Earnings Yield | -1.249 |